1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Vivanza Biosciences
Vivanza Biosciences Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Vivanza Biosciences Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
72.01% Fall from 52W High
-22.7
Dividend yield 1yr %
0
Vivanza Biosciences Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Vivanza Biosciences Quarterly Revenue
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
1.5 Cr | 3 Cr | 2.44 Cr | 4.42 Cr | 6.56 Cr |
Vivanza Biosciences Yearly Revenue
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
27.89 Cr | 18.28 Cr | 11.23 Cr | 10.39 Cr | 10.19 Cr | 2.66 Cr |
Vivanza Biosciences Quarterly Net Profit/Loss
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
0.04 Cr | 0.02 Cr | 0.27 Cr | -0.41 Cr | 0.21 Cr |
Vivanza Biosciences Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
0.55 Cr | 0.6 Cr | 0.33 Cr | 0.08 Cr | -0.21 Cr | -0.44 Cr |
Vivanza Biosciences Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
2.30
10Day EMA
2.30
12Day EMA
2.30
20Day EMA
2.30
26Day EMA
2.30
50Day EMA
2.40
100Day EMA
2.80
200Day EMA
3.80
5Day SMA
2.30
10Day SMA
2.30
20Day SMA
2.20
30Day SMA
2.20
50Day SMA
2.30
100Day SMA
2.80
150Day SMA
3.20
200Day SMA
3.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 61303 Rs | 61303 Rs |
Week Rs | 80275 Rs | 80275 Rs |
Month Rs | 62148 Rs | 62148 Rs |
Resistance & Support
2.28
Pivot
Resistance
First Resistance
2.39
Second Resistance
2.48
Third Resistance
2.59
Support
First Support
2.19
Second support
2.08
Third Support
1.99
Relative Strength Index
49.79
Money Flow Index
46.61
MACD
0
MACD Signal
-0.02
Average True Range
0.13
Average Directional Index
19.02
Rate of Change (21)
6.51
Rate of Change (125)
-37.43
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9.16 | 1.9 | 8.33 | 2.29 | -1.28% | 16.58% | -37.47% | -71.00% | -86.94% | 0.00% | 0.00 | 41.08 | 1.85 | ||
8.71 | 9.57 | 24.96 | 11.14 | -5.47% | 7.31% | -43.06% | -46.18% | -59.81% | 0.00% | 0.00 | 41.08 | 3.87 | ||
Beryl Drugs Ltd. | 22.20 | - | - | - | - | - | - | - | - | - | - | - | - | |
Decipher Labs Ltd. | 11.99 | - | - | - | - | - | - | - | - | - | - | - | - | |
Unjha Formulations Ltd. | 25.53 | - | - | - | - | - | - | - | - | - | - | - | - | |
Hindustan Bio Sciences Ltd. | 7.89 | - | - | - | - | - | - | - | - | - | - | - | - | |
Cian Healthcare Ltd. | 3.10 | - | - | - | - | - | - | - | - | - | - | - | - |
Vivanza Biosciences Company background
Founded in: 1982
Managing director: Jayendra Mehta
Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.The Company is presently engaged in the business of Pharmaceutical Products and Pharma Products.However Competition in the industry is continuously increasing. New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units.The company undertook an expansioncumdiversification programme to increase its capacity from 18 lac pa to 54 lac pa. It also proposed to diversify into the manufacture of small volume parenterals with an installed capacity of 294 lac pa. It came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. Due to recessionary trends which lead to difficult business conditions in the year 19992000, the parenteral industry suffered a setback. As a result of this, the name of the Company was changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd in 2015.The Company acquired 100% Equity Shares of Vivanza Lifesciences Private Limited and by virtue of the holding in Vivanza Lifesciences Private Limited it became Wholly Owned Subsidiary w.e.f. 17/06/2016.
Vivanza Biosciences FAQs
How to buy Vivanza Biosciences shares?
You can easily buy Vivanza Biosciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Vivanza Biosciences stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
